Call for immediate investigation into embalmer clot phenomenon
-
Highlighting the importance of whistleblower reports on abnormal clot. • 0:04
-
Comparison drawn with historical issue of asbestos for contex. • 0:50
-
Critical information shared by a whistleblower regarding embalmer clots in living patient. • 1:27
-
Upcoming release of book on nitric oxide’s impact on healt. • 2:30
-
Announcement of third part of advanced covid 360 course recordin. • 3:05
-
Encouragement for viewers to participate in discussions and presentation. • 3:22
Critical importance of investigating abnormal clots in embalmers for public health and safety.
-
Abnormal clots in embalmers can lead to significant health risks such as stroke and heart issues. • 3:45
-
Researcher Thomas Havland has raised awareness about the high percentage of embalmers experiencing abnormal clots. • 4:56
-
Concerns raised about lack of government or public bodies collecting data on abnormal clots in embalmers. • 5:25
-
Criticism faced by researchers for sharing findings on abnormal clots due to ethical concerns. • 6:25
-
Call for investigation to determine the cause of abnormal clots, whether related to the virus, vaccine, or other factors. • 6:39
-
FDA responds stating no safety signals for fibrous blood clots with covid-19 vaccines based on their monitoring program. • 7:02
Neglected health concerns reminiscent of historical cover-ups in the asbestos industry.
History of asbestos industry negligence leading to health risks and cover-ups.
-
Asbestos industry was a multibillion dollar industry employing over 200,000 people from 1940 to 1980. • 11:13
-
Financial interests and power hindered government intervention in addressing asbestos-related issues. • 11:24
-
Negligence towards worker safety and health for financial gain was evident in the industry. • 11:55
-
Discovery of asbestos health risks dates back to 1929, but industry leaders denied knowledge to evade responsibility. • 12:49
-
Scientific evidence linking asbestos exposure to cancer emerged in 1962, leading to increased awareness. • 13:37
-
Initial safety standards were upgraded in the UK in response to asbestos dangers, but industry manipulation persisted. • 15:04
Historical coverup of health risks, financial implications, and advocacy for change.
-
Long-standing coverup of asbestos risks for financial gai. • 15:29
-
Ongoing compensation for asbestos exposure victims’ familie. • 16:02
-
Importance of advocacy in addressing health and financial implication. • 17:20
-
Need for everyone to recognize the significance of past health issue. • 17:28
-
Urgent call for investigating embalmer clots and potential health risk. • 18:07